METAMYELOCYTE PERCENTAGE INCREASED

METAMYELOCYTE PERCENTAGE INCREASED was reported 24 times

These drug classes are most commonly taken by patients reporting METAMYELOCYTE PERCENTAGE INCREASED:

# Drug Count
0 Benzodiazepine [EPC] 5
1 Janus Kinase Inhibitor [EPC] 5
2 Kinase Inhibitor [EPC] 5
3 Nonsteroidal Anti-inflammatory Drug [EPC] 5
4 CD52-directed Cytolytic Antibody [EPC] 4
5 Corticosteroid [EPC] 4
6 Loop Diuretic [EPC] 4
7 Osmotic Laxative [EPC] 4
8 Potassium Salt [EPC] 4
9 Aldosterone Antagonist [EPC] 3
10 Nucleoside Analog Antiviral [EPC] 3
11 5-alpha Reductase Inhibitor [EPC] 2
12 Angiotensin 2 Receptor Blocker [EPC] 2
13 Angiotensin Converting Enzyme Inhibitor [EPC] 2
14 Antidote [EPC] 2
15 Antidote for Acetaminophen Overdose [EPC] 2
16 Atypical Antipsychotic [EPC] 2
17 Azole Antifungal [EPC] 2
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
19 Endothelin Receptor Antagonist [EPC] 2
20 Iron Chelator [EPC] 2
21 Mucolytic [EPC] 2
22 Non-narcotic Antitussive [EPC] 2
23 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
24 Provitamin D2 Compound [EPC] 2
25 Stimulant Laxative [EPC] 2
26 Sulfonamide Antimicrobial [EPC] 2
27 Xanthine Oxidase Inhibitor [EPC] 2
28 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2
29 Antimetabolite [EPC] 1
30 Calcineurin Inhibitor Immunosuppressant [EPC] 1
31 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
32 Factor Xa Inhibitor [EPC] 1
33 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
34 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
35 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
36 Macrolide Antimicrobial [EPC] 1
37 Nitrate Vasodilator [EPC] 1
38 Oxazolidinone Antibacterial [EPC] 1
39 Phosphodiesterase 5 Inhibitor [EPC] 1
40 Platelet Aggregation Inhibitor [EPC] 1
41 Platinum-based Drug [EPC] 1
42 Prostacycline Vasodilator [EPC] 1
43 Proteasome Inhibitor [EPC] 1
44 Proton Pump Inhibitor [EPC] 1
45 Retinoid [EPC] 1
46 Tumor Necrosis Factor Blocker [EPC] 1
47 Vascular Endothelial Growth Factor Inhibitor [EPC] 1